Neal D. Shore, Mark Tyson, Gautum Agarwal, Evan R. Goldfischer, Michael Brandon Williams, Corine Baayen, Kristian Juul, Per Sandström, Vikram M. Narayan. "ABLE-32: A randomized, controlled, phase 3b clinical trial of nadofaragene firadenovec-vncg versus observation in patients with intermediate-risk non–muscle-invasive bladder cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4632